Founded in 1976, Helsinn is a third-generation, family-owned company with strong pharmaceutical and technical expertise. For fifty years, it has operated with integrity, passion, and quality, consistently promoting innovation for the benefit of patients and embracing sustainable growth as a central element of its strategic vision.
Helsinn Healthcare SA
Helsinn is a global pharmaceutical company that develops, manufactures, launches, and markets products to improve the quality of life of patients with cancer and chronic diseases, with a particular focus on supportive care, oncology, and dermato-oncology.
Headquartered in Lugano, Switzerland, Helsinn has direct commercial operations in the United States, manufacturing operations in Ireland, offices in China, and a network of trusted partners that ensure a commercial presence in 90 countries.
Activities
Main Activity
Licensing-In
Licensing-Out
Development
Co-development (Partial)
Drug Product CMO
Drug development
Drug commercialization
Pre-formulation (Partial)
Other Activities (Partial)
Therapeutic Areas
Cancer supportive therapy
Cardiology (Partial)
Dermatology
Oncology
Pain
Other therapeutic areas
Markets
CH
EU Top 5
Rest of Europe
USA and Canada
Japan
LATAM
MENA
BRICS
ASEAN
Australia
Other market
Drug Stages
Clinical Phase I/Phase III
Phase I - Phase III
Registration
Market
Life cycle management
Drug Product Forms
Injectable
Oral (solid)
Oral (liquid)
Topical
Certifications
Swissmedic
FDA
European Medicines Agency
Korea FDA
GMP
Anvisa
ESG Certifications & Collaborations
GRI
Ecovadis
UN Global Compact
Other
